Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anti-osteoporosis agent-1 (comp 4aa) is an effective RPA (replication protein A) inhibitor, demonstrating potency with an IC50 value of 18 μM [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 2,140.00 | |
50 mg | 6-8 weeks | $ 2,785.00 | |
100 mg | 6-8 weeks | $ 3,520.00 |
Description | Anti-osteoporosis agent-1 (comp 4aa) is an effective RPA (replication protein A) inhibitor, demonstrating potency with an IC50 value of 18 μM [1]. |
In vitro | Anti-osteoporosis agent-1 is an effective molecule that promotes osteoblast cell mineralization and enhances the expression of osteogenic marker genes including Bmp-2, Runx-2, and Type-1col at both the transcriptional and translational levels. Moreover, it demonstrates significant osteogenic activity and possesses notable anti-apoptotic properties at concentrations of 1 pM and 100 pM, thereby increasing osteoblast survival under serum-deprived conditions [1]. |
Molecular Weight | 354.83 |
Formula | C20H19ClN2O2 |
CAS No. | 2761577-50-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Anti-osteoporosis agent-1 2761577-50-6 inhibitor inhibit